🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nicola J. Mason

Parker Institute for Cancer Immunotherapy

ORCID: 0000-0002-6149-4927

Also affiliated with University of Pennsylvania, Philadelphia University

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Development and pharmacokinetic assessment of a fully canine anti-PD-1 monoclonal antibody for comparative translational research in dogs with spontaneous tumors”.

Development and pharmacokinetic assessment of a fully canine anti-PD-1 monoclonal antibody for comparative translational research in dogs with spontaneous tumors

mAbs(2023)10.1080/19420862.2023.2287250

N/A

0.500DataRank · unranked

27 citations

Nicholas Chester, Ailian Xiong, Enrico Radaelli, Hong Wang, Marc Brillantes +5 more

Generation and Validation of an Antibody to Canine CD19 for Diagnostic and Future Therapeutic Purposes

Veterinary Pathology(2020)10.1177/0300985819900352

N/A

0.425DataRank · unranked

16 citations

Alexandra Lockhart, Ailian Xiong, Enrico Radaelli, Patrick Savickas, Avery D. Posey +2 more

CD40 ligand is necessary and sufficient to support primary diffuse large B-cell lymphoma cells in culture: a tool for in vitro preclinical studies with primary B-cell malignancies

UNC Libraries(2020)10.17615/p4pp-wn75

N/A

0DataRank · unranked

2 citations

Matthew Breen, Jaime F. Modiano, Nicola J. Mason, Christina Williams, Timothy D. O’Brien +5 more

A Phase I Clinical Trial of Systemically Delivered NEMO Binding Domain Peptide in Dogs with Spontaneous Activated B-Cell like Diffuse Large B-Cell Lymphoma

UNC Libraries(2020)10.17615/5c02-9x92

N/A

0DataRank · unranked

0 citations

Reema Patel, Kathleen J. Propert, Patrick C. Flood, Erika Krick, Michael J. May +4 more

Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats

Veterinary and Comparative Oncology(2021)10.1111/vco.12677

N/A

0DataRank · unranked

325 citations

Matthew J. Atherton, R. Timothy Bentley, C. Elizabeth Boudreau, Jenna H. Burton, Kaitlin M. Curran +15 more

Genetic re-direction of canine primary T cells for clinical trial use in pet dogs with spontaneous cancer

STAR Protocols(2021)10.1016/j.xpro.2021.100905

N/A

0DataRank · unranked

24 citations

Matthew J. Atherton, Brian Kasper, Kumudhini Preethi Haran, Nicola J. Mason, Antonia Rotolo

Case Report: Clinical and Serological Hallmarks of Cytokine Release Syndrome in a Canine B Cell Lymphoma Patient Treated With Autologous CAR-T Cells

Frontiers in Veterinary Science(2022)10.3389/fvets.2022.824982

N/A

0DataRank · unranked

15 citations

Antonia Rotolo, Kumudhini Preethi Haran, Nicola J. Mason, Matthew J. Atherton

Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101241

N/A

0DataRank · unranked

22 citations

Eoin C. Whelan, Matthew J. Atherton, Irina Kulikovskaya, Danuta Jarocha, Joseph A. Fraietta +8 more

Validation of a PD-1/CD28 chimeric switch receptor to augment CAR-T function in dogs with spontaneous B cell lymphoma

iScience(2024)10.1016/j.isci.2024.110863

N/A

0DataRank · unranked

7 citations

Ayano Kudo, Antonia Rotolo, Kay Foos, Lauren Olenick, Satoshi Takagi +2 more

Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2

Molecular Therapy(2025)10.1016/j.ymthe.2025.02.023

N/A

0DataRank · unranked

11 citations

Laura E. Selmic, Audrey Ruple, Cheryl A. London, Lisa G. Barber, Kristen Weishaar +28 more

Innate iNKT cells: from biological insight to clinical impact

Frontiers in Immunology(2025)10.3389/fimmu.2025.1653183

N/A

0DataRank · unranked

6 citations

Nicola J. Mason, Mark A. Exley, Antonia Rotolo

NEMO-Binding Domain Peptide Inhibits Constitutive NF- B Activity and Reduces Tumor Burden in a Canine Model of Relapsed, Refractory Diffuse Large B-Cell Lymphoma

UNC Libraries(2020)10.17615/xthe-wt53

N/A

0DataRank · unranked

2 citations

Anita Gaurnier-Hausser, Nicola J. Mason, Michael J. May, Reema Patel, Albert S. Baldwin